Topiramate
Product Images NDC 12634-452

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 12634-452). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotheca Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (452 71)

This is a prescription label for Topiramate, a medication used to treat seizures and prevent migraines. The label includes information about the drug's strength (25mg), NDC number, and quantity (30 tablets) as well as the name and address of the distributor (ApothecIn Phoenix, AZ) and some directions on use. The label warns users to keep the medication in a light-resistant container and to call a doctor for any side effects.*

FDA Label Image

Chemical-structure (Chemical Structure)

FDA Label Image

Figure-1 (Figure 1)

This is a figure showing the Kaplan-Meier Estimates of Cumulative Rates for Time to First Seizure. On the x-axis, there is a timeline in days from 0 to 500. On the y-axis, there is a range of cumulative rates. The figure shows two separate lines for two different treatment groups, Topiramate 50 mg/day and Topiramate 400 mg/day. The graph indicates that the Topiramate 400 mg/day group has a lower cumulative rate for time to the first seizure than the group receiving Topiramate 50 mg/day. The p-value for the comparison is 0.0002.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.